cutr20210217_8k.htm
false 0001162461 0001162461 2021-02-17 2021-02-17
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 

FORM 8-K
 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
 
February 17, 2021
 
 
Date of Report (date of earliest event reported)
 
https://cdn.kscope.io/0092d737b828806b04430e8068f0a8b6-cutr20210217_8kimg001.jpg
 

Cutera, Inc.
(Exact name of Registrant as specified in its charter)
 

 
Delaware
 
000-50644
 
77-0492262
(State or other jurisdiction of
incorporation or organization)
 
(Commission File Number)
 
(I.R.S. Employer
Identification Number)
 
3240 Bayshore Blvd.
Brisbane, California 94005
(Address of principal executive offices)
 
(415) 657-5500
(Registrant’s telephone number, including area code)
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock ($0.001 par value)
CUTR
The NASDAQ Stock Market, LLC
 
 
N/A
(Former name or former address, if changed since last report)
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Rule 12b-2 of the Securities Exchange Act of 1934.
 
Emerging growth company  
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
 
 

 
Item 2.02.
Results of Operations and Financial Condition.
 
On February 17, 2021, Cutera, Inc. (“Cutera” or the “Company”) issued a press release announcing its financial results for the quarter and year ended December 31, 2020. Cutera hereby incorporates by reference herein the information set forth in its press release dated February 17, 2021, a copy of which is attached hereto as Exhibit 99.1. Except as otherwise provided in the press release, the press release speaks only as of the date of such press release and it shall not create any implication that the affairs of Cutera have continued unchanged since such date.
 
The Company will host a live audio webcast for interested parties commencing Wednesday, February 17, 2021 at 1:30 p.m. PDT (4:30 p.m. EDT), during which the Company will discuss the financial results. The conference call will be available to interested parties through a live audio webcast and accessible through the Investor Relations section of the Cutera corporate website at www.cutera.com.
 
The information provided pursuant to this Item 2.02 is to be considered “furnished” pursuant to Item 2.02 of Form 8-K and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended, nor shall it be deemed incorporated by reference into any of Cutera’s reports or filings with the Securities and Exchange Commission, whether made before or after the date hereof, except as expressly set forth by specific reference in such report or filing.
 
Except for the historical information contained in this report, the statements made by Cutera are forward-looking statements that involve risks and uncertainties. All such statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Cutera’s future financial performance could differ significantly from the expectations of management and from results expressed or implied in the press release. Please refer to the last paragraph of the text portion of the press release for further discussion about forward-looking statements. For further information on risk factors, please refer to “Risk Factors” contained in Cutera’s most recently filed Form 10-K and its subsequent filings with the Securities and Exchange Commission, as well as in the press release attached as Exhibit 99.1 hereto. Cutera disclaims any obligation or duty to update or modify these forward-looking statements.
 
 
 
 
 
Item 9.01.
Financial Statements and Exhibits.
 
(d)
Exhibits.
 
     
Exhibit No.
  
Description
   
99.1
  
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
         
 
 
 
 
CUTERA, INC.
     
Date: February 17, 2021
 
 
 
 /s/ ROHAN SETH
 
 
 
 
Rohan Seth
 
 
 
 
Chief Financial Officer
 
 

EXHIBIT 99.1

 

https://cdn.kscope.io/0092d737b828806b04430e8068f0a8b6-logo.jpg

 

 

Cutera, Inc. Announces Fourth Quarter and Full-Year 2020 Financial Results

 

BRISBANE, California, February 17, 2021 ─ Cutera, Inc. (NASDAQ: CUTR) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today reported financial results for the fourth quarter and full year ended December 31, 2020.

 

Fourth Quarter 2020 Financial and Operational Highlights

 

Revenue was $49.9 million in the fourth quarter, a decrease of 4% from the prior-year period and an increase of 28% sequentially. The year-over-year decline was solely attributed to lower levels of capital equipment purchases due to COVID-related disruptions, while patient traffic and energy-based treatment volumes were estimated to be at pre-COVID-19 levels during the quarter.

 

o

Capital Equipment revenue of $30.1 million declined 26% over the prior-year period, while increasing 25% sequentially over the third quarter of 2020.

 

o

Recurring revenue, defined as the combination of Service, Skincare and Consumable Product categories, was $19.8 million during the fourth quarter, growing 80% over the prior-year period and 32% sequentially over the third quarter of 2020.

 

§

Skincare revenue was $10.6 million during the quarter, compared to $2.3 million in the prior-year period, growth of 363%.

 

§

Consumable Product revenue was $3.0 million, growing 19% over the prior-year period and 31% sequentially from the third quarter of 2020, reflecting the continued recovery of energy-based treatment volumes. 

 

§

Service revenue of $6.2 million was flat versus the prior-year period, despite decreased access to practices from COVID-related restrictions.

Gross Margin was 56.2% for fourth quarter 2020 compared to 55.6% in the prior-year period. Impacts from lower capital equipment production volumes and product mix shift were offset by reductions in fixed overhead and manufacturing efficiencies.

 

 

 

Operating Expense improvements provided a year-over-year reduction of $4.1 million in the quarter, driven by lower selling expenses, partially offset by legal expenses.

Net income was $2.2 million, or $0.12 per fully diluted share, as compared to a net loss of ($2.1) million, or ($0.15) per fully diluted share, in the prior-year period.

 

 

Full-Year 2020 Financial and Operational Highlights

 

Revenue was $147.7 million, compared to $181.7 million in 2019.

 

o

Capital Equipment revenue of $90.8 million decreased 35% over 2019.

 

o

Recurring Revenue of $56.9 million increased 38% over 2019, driven by Skincare increase of $16.5M over 2019.

Gross Margin was 51.3% for full-year 2020, as compared to 54.0% in 2019.

Operating Expenses decreased $11.6 million to $98.6 million, a decline of 11% over 2019.

Net loss was $23.9 million, or ($1.43) per fully diluted share, as compared to a net loss of $12.3 million, or ($0.88) per fully diluted share, in 2019.

 

“I am pleased with our overall results for the fourth quarter and by the efforts our team put forth over the entirety of 2020.  Our team’s commitment to execution drove steady improvement during the second half of 2020, posting solid results despite the difficult operating environment,” commented Dave Mowry, Chief Executive Officer of Cutera, Inc.  “Our focus and resiliency enabled us to make steady progress on our vital commercial and operational initiatives during 2020.  As a result of these efforts, we enter 2021 well-positioned to accelerate growth and expand profitability as the impact of COVID-19 continues to wane.  I am particularly excited about what lies ahead for Cutera, as we work to bring truly innovative products to market and continue to fortify our business with greater discipline to sustain our financial performance.” 

 

 

2021 Outlook

 

Given the continued uncertainty surrounding the magnitude and duration of the COVID-19 pandemic, the wide range of outcomes for its impact on capital sales, and its potential to delay procedure volumes over the course of the year, the Company will not be providing formal guidance at this time.  

 

 

 

Conference Call

 

The Company’s management will host a conference call to the discuss these results and related matters today at 1:30 p.m. PT (4:30 p.m. ET). Participating on the call will be Dave Mowry, Chief Executive Officer, Rohan Seth, Chief Financial Officer, and, Jason Richey, President.

 

To participate in the conference call, dial 1-877-705-6003 (domestic) or + 1-201-493-6725 (international) and refer to the Conference Code: 13715746.

 

The call will also be webcast and can be accessed from the Investor Relations section of Cutera’s website at http://www.cutera.com/. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

 

About Cutera, Inc.

 

Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has developed innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.

 

 

*Use of Non-GAAP Financial Measures

 

In this press release, in order to supplement the Company’s condensed consolidated financial statements presented in accordance with Generally Accepted Accounting Principles, or GAAP, management has disclosed certain non-GAAP financial measures for the statement of operations and net income (loss) per diluted share. Non-GAAP adjustments include stock-based compensation, depreciation, amortization, executive and other non-recurring separation costs, customer relationship management (“CRM”) and enterprise resource planning (“ERP”) system costs, and non-recurring legal and litigation costs, as well as the net tax impact of excluding these items. From time to time in the future, there may be other items that we may exclude if the Company believes that doing so is consistent with the goal of providing useful information to investors and management. The Company has provided a reconciliation of each non-GAAP financial measure used in this earnings release to the most directly comparable GAAP financial measure. Forward-looking non-GAAP measures include adjusted EBITDA. The Company defines adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, stock-based compensation, executive and other non-recurring separation costs, CRM and ERP system costs, and non-recurring legal and litigation costs.

 

 

 

Company management uses these measurements as aids in monitoring the Company’s ongoing financial performance from quarter to quarter, and year to year, on a regular basis and for benchmarking against other similar companies. Non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. These non-GAAP financial measures should be considered along with, but not as alternatives to, the operating performance measure as prescribed by GAAP. Non-GAAP financial measures for the statement of operations and net income per diluted share exclude the following:

 

Non-cash expenses for stock-based compensation. The Company has excluded the effect of stock-based compensation expenses in calculating its non-GAAP operating expenses and net income measures. Although stock-based compensation is a key incentive offered to its employees, the Company continues to evaluate its business performance excluding stock-based compensation expenses. The Company records stock-based compensation expense related to grants of options, employee stock purchase plan, and performance and restricted stock. Depending upon the size, timing and the terms of the grants, this expense may vary significantly but will recur in future periods. The Company believes that excluding stock-based compensation better allows for comparisons to its peer companies;

 

Depreciation and amortization. The Company has excluded depreciation and amortization expense in calculating its non-GAAP operating expenses and net income measures. Depreciation and amortization are non-cash charges to current operations;

 

Executive and other non-recurring separation costs. We have excluded costs associated with the resignation of our former Executive Officers in calculating our non-GAAP operating expenses and net income measures. We exclude these and other non-recurring employee separation costs because we believe that these items do not reflect future operating expenses;

 

 

 

Customer Relationship Management. We have excluded CRM system costs related to direct and incremental costs incurred in connection with our multi-phase implementation of a new CRM solution and the related technology infrastructure costs. We exclude these costs because we believe that these items do not reflect future operating expenses and will be inconsistent in amounts and frequency making it difficult to contribute to a meaningful evaluation of our operating performance;

 

Enterprise Resource Planning. We have excluded ERP system costs related to direct and incremental costs incurred in connection with our multi-phase implementation of a new ERP solution and the related technology infrastructure costs. We exclude these costs because we believe that these items do not reflect future operating expenses and will be inconsistent in amounts and frequency making it difficult to contribute to a meaningful evaluation of our operating performance; and

 

Non-recurring legal and litigation costs.  We have excluded costs incurred related to third party litigation and  disputes, that are of a non-recurring nature.

 

The Company believes that excluding all of the items above allows users of its financial statements to better review and assess both current and historical results of operations.

 

 

Safe Harbor Statement

 

Certain statements in this press release, other than purely historical information, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements include, but are not limited to, Cutera’s plans, objectives, strategies, financial performance and outlook, CFO and other senior leadership searches, product launches and performance, trends, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, the Company’s actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “seek,” “guidance,” “predict,” “potential,” “likely,” “believe,” “will,” “should,” “expect,” “anticipate,” “estimate,” “plan,” “intend,” “forecast,” “foresee” or variations of these terms and similar expressions, or the negative of these terms or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Cutera's actual results to differ materially from the statements contained herein. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements. There are a number of risks, uncertainties and other important factors, many of which are beyond the Company’s control, that could cause its actual results to differ materially from the forward-looking statements contained in this press release, including those described in the “Risk Factors” section of Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, the Registration Statement on Form S-8 and other documents filed from time to time with the United States Securities and Exchange Commission by Cutera.

 

 

 

All information in this press release is as of the date of its release. Accordingly, undue reliance should not be placed on forward-looking statements. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events. If the Company updates one or more forward-looking statements, no inference should be drawn that it will make additional updates with respect to those or other forward-looking statements. Cutera's financial performance for the fourth quarter and full year ended December 31, 2020, as discussed in this release, is preliminary and unaudited, and subject to adjustment.

 

The financial data presented for the year ended December 31, 2020 should be considered preliminary and could be subject to change, as the Company’s independent auditor has not completed their audit.

 

 

 

Cutera, Inc.

Anne Werdan

Director, Investor Relations

415-657-5500

awerdan@cutera.com 

 

 

 

CUTERA, INC. 

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands) 

(unaudited) 

 

 

   

December 31,

   

December 31,

 

 

 

2020

   

2019

 
Reporting Unit Balance Sheet                

Assets

               

Current assets:

               

Cash and cash equivalents

  $ 47,047     $ 26,316  

Marketable investments

    -       7,605  

Accounts receivable, net

    21,962       21,556  

Inventories

    28,508       33,921  

Other current assets and prepaid expenses

    8,779       5,648  

Total current assets

    106,296       95,046  
                 

Property and equipment, net

    2,299       2,817  

Deferred tax asset

    643       423  

Goodwill

    1,339       1,339  

Operating lease right-of-use assets

    17,076       7,702  

Other long-term assets

    5,080       6,411  

Total assets

  $ 132,733     $ 113,738  
                 

Liabilities and Stockholders' Equity

               

Current liabilities:

               

Accounts payable

  $ 6,684     $ 12,685  

Accrued liabilities

    31,079       30,307  

Operating leases liabilities

    2,260       2,800  

Extended warranty liabilities

    1,216       1,999  

Deferred revenue

    9,489       10,831  

Total current liabilities

    50,728       58,622  
                 

Deferred revenue, net of current portion

    1,748       3,391  

Income tax liability

    -       93  

PPP Loan payable

    7,185       -  

Operating lease liabilities, net of current portion

    15,950       5,112  

Other long-term liabilities

    242       578  

Total liabilities

    75,853       67,796  
                 

Stockholders’ equity:

               

Common stock

    18       14  

Additional paid-in capital

    117,097       82,346  

Accumulated deficit

    (60,235 )     (36,358 )

Accumulated other comprehensive loss

    -       (60 )

Total stockholders' equity

    56,880       45,942  

Total liabilities and stockholders' equity

  $ 132,733     $ 113,738  

 

 

 

CUTERA, INC. 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited) 

 

 

   

Three Months Ended

   

Twelve Months Ended

 
                                 
   

December 31,

   

December 31,

   

December 31,

   

December 31,

 
   

2020

   

2019

   

2020

   

2019

 
                                 

Products

  $ 43,723     $ 45,593       125,113     $ 158,638  

Service

    6,220       6,202       22,570       23,074  

Total net revenue

    49,943       51,795       147,683       181,712  
                                 

Products

    17,999       18,415       58,325       64,693  
                                 

Service

    3,878       4,590       13,586       18,856  

Total cost of revenue

    21,877       23,005       71,911       83,549  

Gross profit

    28,066       28,790       75,772       98,163  

Gross margin %

    56 %     56 %     51 %     54 %
                                 

Operating expenses:

                               

Sales and marketing

    14,656       20,323       52,766       71,109  

Research and development

    4,029       4,463       14,322       15,085  

General and administrative

    7,938       5,933       31,512       24,033  

Total operating expenses

    26,623       30,719       98,600       110,227  

Income (Loss) from operations

    1,443       (1,929 )     (22,828 )     (12,064 )

Interest and other income (expense), net

    7       (20 )     (579 )     (199 )

Income (Loss) before income taxes

    1,450       (1,949 )     (23,407 )     (12,263 )

Income tax expense (benefit)

    (738 )     139       470       85  

Net Income (loss)

  $ 2,188     $ (2,088 )   $ (23,877 )   $ (12,348 )
                                 

Net Income (loss) per share:

                               

Basic

  $ 0.12     $ (0.15 )   $ (1.43 )   $ (0.88 )

Diluted

  $ 0.12     $ (0.15 )   $ (1.43 )   $ (0.88 )
                                 

Weighted-average number of shares used in per share calculations:

                 

Basic

    17,653       14,261       16,691       14,096  

Diluted

    17,840       14,261       16,691       14,096  

 

 

 

CUTERA, INC. 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands) 

(unaudited) 

 

 

   

Three Months Ended

   

Twelve Months Ended

 
   

December 31,

   

December 31,

   

December 31,

   

December 31,

 
   

2020

   

2019

   

2020

   

2019

 

Cash flows from operating activities:

                               

Net income (loss)

  $ 2,188     $ (2,088 )   $ (23,877 )   $ (12,348 )

Adjustments to reconcile net loss to net cash used in operating activities:

                               

Stock-based compensation

    2,052       2,828       10,109       9,832  

Depreciation of tangible assets

    338       364       1,394       1,548  

Amortization of contract acquisition costs

    579       746       2,593       2,915  

Impairment of capitalized cloud computing costs

    -       -       805       -  

Change in deferred tax asset

    (143 )     36       (220 )     34  

Provision for credit losses

    394       (57 )     2,144       590  

Loss on sale of marketable investments, net

    -               60       -  

Change in right-of-use asset/liability due to modification

    705       -       955       -  

Other

    183       72       453       127  

Changes in assets and liabilities:

                               

Accounts receivable

    (4,759 )     1,723       (2,550 )     (2,509 )

Inventories

    825       121       5,413       (5,907 )

Other current assets and prepaid expenses

    (1,891 )     (339 )     (3,164 )     (1,762 )

Other long-term assets

    (366 )     (747 )     (2,067 )     (3,355 )

Accounts payable

    (148 )     (1,455 )     (6,034 )     1,406  

Accrued liabilities

    5,450       2,257       891       7,157  

Extended warranty liabilities

    (281 )     (233 )     (783 )     (1,160 )

Other long-term liabilities

    -       -       -       (140 )

Deferred revenue

    (587 )     749       (2,985 )     1,656  

Income tax liability

    (93 )     -       (93 )     (301 )

Net cash provided by (used in) operating activities

    4,446       3,977       (16,956 )     (2,217 )
                                 

Cash flows from investing activities:

                               

Acquisition of property, equipment and software

    (505 )     (467 )     (1,279 )     (991 )

Disposal of property and equipment

    30       -       30       45  

Proceeds from sales of marketable investments

    5,648       -       5,648       -  

Proceeds from maturities of marketable investments

    9,050       3,250       28,050       14,700  

Purchase of marketable investments

    (1,649 )     (4,383 )     (26,060 )     (12,687 )

Net cash provided by (used in) investing activities

    12,574       (1,600 )     6,389       1,067  
                                 

Cash flows from financing activities:

                               

Proceeds from exercise of stock options and employee stock purchase plan

    723       1294       1579       2894  

Proceeds from long-term debt

    -       -       7,167       -  

Gross proceeds from equity offering

    -       -       28,798       -  

Offering costs on the equity offering

    -       -       (2,303 )     -  

Taxes paid related to net share settlement of equity awards

    (88 )     (81 )     (3,428 )     (831 )

Payments on finance lease obligations

    (2 )     (153 )     (515 )     (649 )

Net cash provided by financing activities

    633       1,060       31,298       1,414  
                                 

Net increase in cash and cash equivalents

    17,653       3,437       20,731       264  

Cash and cash equivalents at beginning of period

    29,394       22,879       26,316       26,052  

Cash and cash equivalents at end of period

  $ 47,047     $ 26,316     $ 47,047     $ 26,316  

 

 

 

CUTERA, INC. 

CONSOLIDATED FINANCIAL HIGHLIGHTS

(in thousands, except percentage data)

(unaudited) 

 

 

   

Three Months Ended

   

% Change

   

Twelve Months Ended

   

% Change

 
   

December 31,

   

December 31,

   

2020 Vs

   

December 31,

   

December 31,

   

2020 Vs

 
   

2020

   

2019

   

2019

   

2020

   

2019

   

2019

 

Revenue By Geography:

                                               

United States

  $ 21,060     $ 31,271       -33 %   $ 61,202     $ 106,243       -42 %

International

    28,883       20,524    

+41

%     86,481       75,469    

+15

%

Total Net Revenue

  $ 49,943     $ 51,795       -4 %   $ 147,683     $ 181,712       -19 %

International as a percentage of total revenue

    58 %     40 %             59 %     42 %        
                                                 

Revenue By Product Category:

                                               

Systems

                                               

- North America

  $ 18,426     $ 28,526       -35 %   $ 50,721     $ 96,718       -48 %

- Rest of World

    11,719       12,246       -4 %     40,045       43,760       -8 %

Total Systems

    30,145       40,772       -26 %     90,766       140,478       -35 %

Consumables

    3,023       2,539    

+19

%     9,286       9,648       -4 %

Skincare

    10,555       2,282    

+363

%     25,061       8,512    

+194

%

Total Products

    43,723       45,593       -4 %     125,113       158,638       -21 %
                                                 

Service

    6,220       6,202    

+0%

      22,570       23,074       -2 %

Total Net Revenue

  $ 49,943     $ 51,795       -4 %   $ 147,683     $ 181,712       -19 %

 

 

 

   

Three Months Ended

   

Twelve Months Ended

 
   

December 31,

   

December 31,

   

December 31,

   

December 31,

 
   

2020

   

2019

   

2020

   

2019

 

Pre-tax Stock-Based Compensation Expense:

                               

Cost of revenue

  $ 306     $ 469     $ 1,665     $ 1,572  

Sales and marketing

    767       1,430       3,385       4,510  

Research and development

    325       460       1,669       1,536  

General and administrative

    654       469       3,390       2,214  
    $ 2,052     $ 2,828     $ 10,109     $ 9,832  

 

 

 

CUTERA, INC. 

RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

TO  NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited) 

 

 

   

Three Months Ended December 31, 2020

   

Three Months Ended December 31, 2019

 
   

GAAP

   

Depreciation
and
Amortization

   

Stock-Based
Compensation

   

Legal - Former CFO
Settlement/

Lutronic

   

Taxes and
Other Adjustments

   

Non-GAAP

   

GAAP

   

Depreciation
and
Amortization

   

Stock-Based
Compensation

   

CRM and ERP
Implementation/
write-off

   

Taxes and
Other Adjustments

   

Non-GAAP

 
                                                                                                 

Net revenue

  $ 49,943       -       -       -       -     $ 49,943     $ 51,795       -       -       -       -     $ 51,795  

Cost of revenue

    21,877       (174 )     (306 )     -       275       21,672       23,005       (136 )     (469 )     -       -       22,400  

Gross profit

    28,066       174       306       -       (275 )     28,271       28,790       136       469       -       -       29,395  

Gross margin %

    56 %                                     57 %     56 %                                     57 %
                                                                                                 

Operating expenses:

                                                                                               

Sales and marketing

    14,656       (682 )     (767 )     -       -       13,207       20,323       (910 )     (1,430 )     (124 )     -       17,859  

Research and development

    4,029       (34 )     (325 )     -       -       3,670       4,463       (35 )     (460 )     -       -       3,968  

General and administrative

    7,938       (27 )     (654 )     (566 )     -       6,691       5,933       (29 )     (469 )     41       -       5,476  

Total operating expenses

    26,623       (743 )     (1,746 )     (566 )     -       23,568       30,719       (974 )     (2,359 )     (83 )     -       27,303  

Income (loss) from operations

    1,443       917       2,052       566       (275 )     4,703       (1,929 )     1,110       2,828       83       -       2,092  

Interest and other expense, net

    7       -       -       -       -       7       (20 )     -       -       -       -       (20 )

Income (loss) before income taxes

    1,450       917       2,052       566       (275 )     4,710       (1,949 )     1,110       2,828       83       -       2,072  

Provision (benefit) for income taxes

    (738 )     -       -       -       -       (738 )     139       -       -       -       (201 )     (62 )

Net income (loss)

  $ 2,188     $ 917     $ 2,052     $ 566     $ (275 )   $ 5,448     $ (2,088 )   $ 1,110     $ 2,828     $ 83     $ 201     $ 2,134  
                                                                                                 

Net income (loss) per share:

                                                                                               

Basic

  $ 0.12                                     $ 0.31     $ (0.15 )                                   $ 0.15  

Diluted

  $ 0.12                                     $ 0.31     $ (0.15 )                                   $ 0.14  
                                                                                                 

Weighted-average number of shares used in per share calculations:

                                                                                               

Basic

    17,653                                       17,653       14,261                                       14,261  

Diluted

    17,840                                       17,840       14,261                                       14,904  

 

 

Operating expenses as a % of net revenue

 

GAAP

   

Non-GAAP

   

GAAP

   

Non-GAAP

 

Sales and marketing

    29.2 %     26.4 %     39.2 %     34.5 %

Research and development

    8.1 %     7.2 %     8.6 %     7.7 %

General and administrative

    15.9 %     13.4 %     11.5 %     10.6 %
      53.3 %     47.2 %     59.3 %     52.7 %

 

 

 

CUTERA, INC. 

RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

TO  NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited) 

 

 

   

Twelve Months Ended December 31, 2020

   

Twelve Months Ended December 31, 2019

 
   

GAAP

   

Depreciation
and
Amortization

   

Stock-Based
Compensation

   

CRM and ERP
Implementation/

write-off

   

Severance (RIF)

   

Legal -Former CFO Settlement/

Lutronic

   

Taxes and
Other Adjustments

   

Non-GAAP

   

GAAP

   

Depreciation
and
Amortization

   

Stock-Based
Compensation

   

CRM and ERP
Implementation/ write-off

   

Taxes and
Other Adjustments

   

Non-GAAP

 
                                                                                                                 

Net revenue

  $ 147,683       -       -       -                       -     $ 147,683     $ 181,712     $ -     $ -     $ -     $ -     $ 181,712  

Cost of revenue

    71,911       (591 )     (1,665 )     -       (318 )     -       275       69,612       83,549       (522 )     (1,572 )     -       -       81,455  

Gross profit

    75,772       591       1,665       -       318       -       (275 )     78,071       98,163       522       1,572       -       -       100,257  

Gross margin %

    51 %                                                     53 %     54 %                                     55 %
                                                                                                                 

Operating expenses:

                                                                                                               

Sales and marketing

    52,766       (3,136 )     (3,384 )     -       (274 )     -       -     $ 45,972       71,109       (3,627 )     (4,510 )     (325 )     -       62,647  

Research and development

    14,322       (149 )     (1,670 )     -       (130 )     -       -       12,373       15,085       (109 )     (1,536 )     -       -       13,440  

General and administrative

    31,512       (111 )     (3,390 )     (1,139 )     (101 )     (1,925 )     (324 )     24,522       24,033       (205 )     (2,214 )     (1,089 )     (614 )     19,911  

Total operating expenses

    98,600       (3,396 )     (8,444 )     (1,139 )     (505 )     (1,925 )     (324 )     82,867       110,227       (3,941 )     (8,260 )     (1,414 )     (614 )     95,998  

Income (loss) from operations

    (22,828 )     3,987       10,109       1,139       823       1,925       49       (4,796 )     (12,064 )     4,463       9,832       1,414       614       4,259  

Interest and other expense, net

    (579 )     -       -       -       -               -       (579 )     (199 )     -       -       -       -       (199 )

Income (loss) before income taxes

    (23,407 )     3,987       10,109       1,139       823       1,925       49       (5,375 )     (12,263 )     4,463       9,832       1,414       614       4,060  

Provision (benefit) for income taxes

    470       -       -       -       -       -       9       479       85       -       -       -       87       172  

Net income (loss)

  $ (23,877 )   $ 3,987     $ 10,109     $ 1,139     $ 823     $ 1,925     $ 40     $ (5,854 )   $ (12,348 )   $ 4,463     $ 9,832     $ 1,414     $ 527     $ 3,888  
                                                                                                                 

Net income (loss) per share:

                                                                                                               

Basic

  $ (1.43 )                                                   $ (0.35 )   $ (0.88 )                                   $ 0.28  

Diluted

  $ (1.43 )                                                   $ (0.35 )   $ (0.88 )                                   $ 0.27  
                                                                                                                 

Weighted-average number of shares used in per share calculations:

                                                                                                               

Basic

    16,691                                                       16,691       14,096                                       14,096  

Diluted

    16,691                                                       16,691       14,096                                       14,512  

 

 

Operating expenses as a % of net revenue

 

GAAP

   

Non-GAAP

   

GAAP

   

Non-GAAP

 

Sales and marketing

    35.7 %     31.1 %     39.1 %     34.5 %

Research and development

    9.6 %     8.3 %     8.3 %     7.4 %

General and administrative

    21.3 %     16.6 %     13.2 %     11.0 %
      66.8 %     56.1 %     60.7 %     52.8 %

 

 

 

CUTERA, INC. 

RECONCILIATION OF LOSS TO ADJUSTED EBITDA

(in thousands)

(unaudited) 

 

 

   

Three Months

Ended

   

Twelve Months

Ended

 
   

December 31, 2020

 
                 

Net income (loss)

  $ 2,188     $ (23,877 )

Adjustments:

               

Stock-based compensation

    2,052       10,109  

Depreciation and amortization

    917       3,987  

CRM and ERP implementation costs

    -       1,139  

Severance (RIF)

    -       823  

Legal -Former CFO Settlement/Lutronic

    566       1,925  

Other adjustments

    (275 )     49  

Interest and other expense, net

    (7 )     579  

Provision (benefit) for income taxes

    (738 )     470  

Total adjustments

  $ 2,515     $ 19,081  
                 

Adjusted EBITDA

  $ 4,703     $ (4,796 )